<div id="readability-page-1"><p>RBC Capital analyst Ben Hendrix maintained a Buy rating on HCA Healthcare yesterday and set a price target of $525.00.</p><h3>Claim 50% Off TipRanks Premium and Invest with Confidence </h3><ul><li>Unlock  hedge-fund level data  and  powerful investing tools  designed to help you make smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  so your portfolio is always positioned for maximum potential</li></ul> <p>Hendrix covers the Healthcare sector, focusing on stocks such as CVS Health, Brookdale Senior Living, and Select Medical. According to TipRanks, Hendrix has an average return of <span>4.6%</span> and a 51.76% success rate on recommended stocks. </p> <p>In addition to RBC Capital, HCA Healthcare also received a Buy from Mizuho Securities’s Ann Hynes in a report issued on December 18. However, on December 15, Morgan Stanley downgraded HCA Healthcare (NYSE: HCA) to a Sell.</p></div>

<p>RBC Capital analyst Ben Hendrix maintained a Buy rating on HCA Healthcare with a price target of $525. Mizuho Securities also rated it a Buy, while Morgan Stanley downgraded it to a Sell. Hendrix, who covers the Healthcare sector, has an average return of 4.6% and a 51.76% success rate on recommended stocks.</p>

RBC Capital Sticks to Their Buy Rating for HCA Healthcare (HCA)